Clinical trial
Andrographolides With or Without Capecitabine for Elderly Patients With Locally Advanced or Recurrent or Metastasis Inoperable Colorectal Cancer: a Randomized, Open-label Trial.
NCT01993472 is registered in ClinicalTrials.gov with Gu Yanhong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Andrographolides With or Without Capecitabine for Elderly Patients With Locally Advanced or Recurrent or Metastasis Inoperable Colorectal Cancer: a Randomized, Open-label Trial.
- Lead sponsor
- Gu Yanhong
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 30, 2013
- Completion date
- December 31, 2016
- Enrollment
- 308 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.